Clinician Scientist PRogram In Vascular MEdicine: PRIME

血管医学临床科学家项目：PRIME

• 批准号: 413635475
• 负责人: Professor Dr. Steffen Massberg
• 金额: --
• 依托单位: Institut für Klinische Pharmakologie
• 依托单位国家: 德国
• 项目类别: Research Grants
• 资助国家: 德国
• 项目状态: 未结题
• 来源: https://gepris.dfg.de/gepris/projekt/413635475?language=en
• 关键词: Clinician; Scientist; PRogram; Vascular; MEdicine

Vascular diseases are among the leading causes of mortality and morbidity worldwide. This leads to enormous problems in health care and has negative socio-economic effects. A better understanding of the pathophysiological basis of vascular diseases, the identification of new therapeutic targets and the transfer of research concepts into clinical applications are important prerequisites for the treatment and prevention of vascular diseases. Clinician scientists are of outstanding importance for the identification and successful clinical establishment of new therapies. However, there is a significant shortage of doctors working at both “bench” and “bedside”. This is in part due to the fact that the combined clinical-scientific training of clinician scientists is only inadequately regulated. Following the tender of the German Research Foundation (DFG) in 2018, we applied for the establishment of a research and training program with the title “Clinician Scientist PRrogram In Vascular Medicine (PRIME)” for young licensed doctors. The central goal of the program is the targeted promotion of clinical and scientific competencies of young physicians active with a vascular focus. Over a period of 3 years, medical professionals in specialist training have the opportunity to flexibly use 50% of their working hours as protected research time. The program is accompanied by interdisciplinary and individually adapted training within a structured curriculum as well as close supervision by research-experienced mentors. The program promotes the successful implementation of experimental, translational and clinical research, and at the same time ensures clinical training as a specialist without significant delay. The training program is accessible to vascular-interested researching doctors from all specialist disciplines, and also takes into account smaller specialist disciplines (e.g. cardiac surgery, laboratory medicine), for which participation in such programs has often been difficult up to now. In summary, we established an interdisciplinary, vascular-focused training program termed “PRIME”, which makes an important contribution to the structured, scientifically sound training of researching doctors. The program has been integrated into the framework of the Munich Clinician Scientist Program (MCSP). With the accompanying sustainability concept of the LMU Medical Faculty, we are opening up new career paths and ensure that talented doctors are promoted beyond their specialist qualification. PRIME will therefore make an important contribution to the research, treatment and prevention of vascular diseases.

血管疾病是世界范围内死亡和发病的主要原因之一。这导致了医疗保健方面的巨大问题，并产生了负面的社会经济影响。更好地了解血管疾病的病理生理基础，确定新的治疗靶点，将研究理念转化为临床应用，是治疗和预防血管疾病的重要前提。临床科学家对于新疗法的识别和成功的临床建立具有突出的重要性。然而，同时在“板凳”和“床边”工作的医生严重短缺。这在一定程度上是由于临床-科学相结合的临床科学培训只是没有得到充分的监管。继2018年德国研究基金会(DFG)招标后，我们申请建立一个面向年轻执业医生的研究和培训计划，标题为《血管医学临床医生科学家程序(PRIME)》。该计划的中心目标是有针对性地促进活跃在血管领域的年轻医生的临床和科学能力。在3年的时间里，专科培训中的医疗专业人员有机会灵活地使用其工作时间的50%作为受保护的研究时间。该计划伴随着在结构化课程中进行的跨学科和个别适应的培训，以及有研究经验的导师的密切监督。该计划促进了实验、转化和临床研究的成功实施，同时确保了作为专家的临床培训没有明显延误。该培训计划对来自所有专科学科的对血管感兴趣的研究医生开放，并考虑到较小的专科学科(例如心脏外科、实验室医学)，这些学科到目前为止参与此类项目往往很困难。总而言之，我们建立了一个跨学科的、以血管为重点的培训计划，名为“Prime”，这对研究医生的结构合理、科学合理的培训做出了重要贡献。该计划已纳入慕尼黑临床医生科学家计划(MCSP)的框架。伴随着LMU医学院的可持续发展理念，我们正在开辟新的职业道路，并确保有才华的医生得到晋升，超越他们的专科资格。因此，PRIME将为血管疾病的研究、治疗和预防做出重要贡献。